Robert Mitchell Selected Research

Robert Mitchell Research Topics

Disease

5	Malaria 04/2016 - 05/2006
4	Infections 04/2024 - 05/2006
4	Neoplasms (Cancer) 02/2024 - 10/2002
3	Hypertrophy 01/2021 - 01/2015
2	Fibrosis (Cirrhosis) 01/2022 - 11/2018
2	Hypoxia (Hypoxemia) 01/2021 - 10/2002
2	Cachexia 01/2021 - 04/2020
2	Inflammation (Inflammations) 01/2021 - 11/2018
2	Obesity 01/2020 - 01/2015
2	Anemia 05/2015 - 05/2006
2	Starvation 01/2015 - 01/2015
1	Breakthrough Infections 04/2024
1	COVID-19 04/2024
1	Breast Neoplasms (Breast Cancer) 02/2024
1	Dementia (Dementias) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Progeria (Hutchinson Gilford Syndrome) 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Infertility (Sterility) 01/2021
1	Blister (Bulla) 01/2021
1	Atrophy 01/2021
1	Necrotizing Enterocolitis 01/2021
1	Sepsis (Septicemia) 08/2020
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 07/2020
1	Neuromuscular Diseases (Neuromuscular Disease) 04/2020
1	Sarcopenia 04/2020
1	Seminoma 04/2020
1	Platelet Glycoprotein IV Deficiency 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Hepatitis C 06/2019
1	Coinfection 04/2019
1	Bites and Stings (Sting) 01/2019
1	Osteoporosis 01/2019
1	Polyploidy 01/2019
1	Cystic Fibrosis (Mucoviscidosis) 01/2014
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Bacterial Infections (Bacterial Infection) 06/2009
1	Hyperplasia 01/2003
1	Colonic Neoplasms (Colon Cancer) 10/2002

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2002
5	Activins (Activin)IBA 01/2022 - 01/2019
5	MyostatinIBA 01/2021 - 01/2015
3	LigandsIBA 01/2021 - 01/2019
3	Macrophage Migration-Inhibitory FactorsIBA 05/2015 - 05/2006
2	AntigensIBA 04/2024 - 12/2015
2	VaccinesIBA 04/2024 - 12/2013
2	LipopolysaccharidesIBA 01/2023 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2014
2	activin AIBA 01/2022 - 01/2021
2	activin receptor type II-BIBA 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 10/2002
2	LipidsIBA 01/2021 - 01/2020
2	CytokinesIBA 11/2018 - 06/2009
2	Immunoglobulin G (IgG)IBA 12/2015 - 12/2013
1	Neutral CeramidaseIBA 02/2024
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	SphingolipidsIBA 01/2023
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2023
1	Conditioned Culture MediaIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 08/2020
1	DystrophinIBA 07/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 06/2019
1	RNA (Ribonucleic Acid)IBA 04/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2019
1	Snake Venoms (Snake Venom)IBA 01/2019
1	CollagenIBA 01/2019
1	Viper Venoms (Viper Venom)IBA 01/2019
1	NF-kappa B (NF-kB)IBA 11/2018
1	Surface Antigens (Surface Antigen)IBA 04/2016
1	Interleukin-5 (Interleukin 5)IBA 12/2013
1	FlagellinIBA 12/2013
1	Peptides (Polypeptides)IBA 01/2012
1	aluminum sulfate (alum)IBA 01/2012
1	AntibodiesIBA 01/2012
1	Erythropoietin FDA Link 05/2006
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2003
1	Phosphotransferases (Kinase)IBA 10/2002
1	FructoseIBA 10/2002
1	NucleotidesIBA 10/2002

Therapy/Procedure

2	Therapeutics 08/2020 - 01/2015